Parliamentary Panel Slams India
Despite exporting cheap medicines globally, domestic consumers face high retail prices driven by manufacturer and intermediary markups. R. Suryamurthy Parliament of India has raised serious concerns over Indias drug pricing regime, highlighting that nearly 82% of the pharmaceutical market remains outside direct price regulation. While India is globally recognized as the pharmacy of the world []